Among the MLL-r AML cell lines tested, we observed variations in sensitivity to MS67 with MV4;11 and EOL-1 cells being the most sensitive and RS4;11 and THP-1 cells being least sensitive to MS67 treatment. Here, KMT2A is linked to acute myeloid leukemia.